SCHEMBL4197224

SCHEMBL4197224

C[C@@H](CC1CCCC1)NCc1ccccc1NS(=O)(=O)c1ccc(-c2cccnc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.46
PKM P14618 1/20 0.46
GHSR Q92847 1/20 0.41
LMNA P02545 3/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
ALDH1A1 P00352 3/20 0.39
POLB P06746 2/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
MAPT P10636 2/20 0.39
HTT P42858 2/20 0.39
TSHR P16473 1/20 0.39
OGG1 O15527 1/20 0.39
PTGES O14684 2/20 0.38
ABCB1 P08183 1/20 0.38
ABCC1 P33527 1/20 0.38
NAMPT P43490 2/20 0.38
CKS1B P61024 1/20 0.37
SKP2 Q13309 1/20 0.37
CA12 O43570 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4203511 0.99 KDM4E (0.47) KDM4EPKMGHSRLMNASMN1; SMN2
SCHEMBL4200138 0.91 KDM4E (0.47) KDM4EPKMGHSRLMNASMN1; SMN2
SCHEMBL4194965 0.90 KDM4E (0.48) KDM4EPKMGHSRLMNASMN1; SMN2
SCHEMBL4200119 0.85 POLB (0.47) KDM4EPKMGHSRLMNASMN1; SMN2
SCHEMBL4193471 0.85 GHSR (0.43) KDM4EPKMGHSRLMNASMN1; SMN2
SCHEMBL4191293 0.85 KDM4E (0.50) KDM4EPKMLMNASMN1; SMN2ALDH1A1
SCHEMBL4198111 0.85 KDM4E (0.47) KDM4EPKMGHSRLMNASMN1; SMN2
SCHEMBL4185878 0.85 KDM4E (0.45) KDM4EPKMLMNASMN1; SMN2ALDH1A1
SCHEMBL14344109 0.84 GHSR (0.42) KDM4EPKMGHSRLMNASMN1; SMN2
SCHEMBL4192690 0.84 KDM4E (0.46) KDM4EPKMLMNASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP claimed
US-8076370-B2 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2011-12-13 US claimed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US claimed
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP disclosed
US-8076370-B2 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2011-12-13 US disclosed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215764-A1 Antimicrobial agents TUFM, RPS17, HARS1 KDM4E 3328/4885PKM 1855/4885GHSR 3645/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.